The once-a-day treatment, which acts on brain chemicals that affect mood and appetite, had initially been OK’d for ...

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

FDA approves Addyi for low sexual desire in postmenopausal women under 65, expanding use beyond premenopausal patients for ...

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.

Addyi, the first FDA-approved medication for low libido in women under 65, offers a new treatment option. Learn about its ...

Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows ...

Sprout Pharmaceuticals today announced a monumental milestone for women's health: the U.S. Food and Drug Administration (FDA) ...